Concepts (286)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 27 | 2020 | 3352 | 2.180 |
Why?
|
| Contrast Media | 15 | 2020 | 1077 | 1.680 |
Why?
|
| Carcinogenesis | 3 | 2020 | 195 | 1.220 |
Why?
|
| Vanadates | 8 | 2009 | 29 | 1.180 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 137 | 1.160 |
Why?
|
| Vanadium | 3 | 2015 | 13 | 1.000 |
Why?
|
| Gadolinium DTPA | 7 | 2017 | 261 | 0.930 |
Why?
|
| Electron Spin Resonance Spectroscopy | 15 | 2005 | 306 | 0.910 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2020 | 54 | 0.910 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 114 | 0.850 |
Why?
|
| beta-Lactamases | 5 | 2004 | 52 | 0.720 |
Why?
|
| Arteries | 1 | 2020 | 176 | 0.700 |
Why?
|
| Spin Labels | 8 | 2013 | 102 | 0.690 |
Why?
|
| Mammary Glands, Animal | 5 | 2020 | 78 | 0.640 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 261 | 0.630 |
Why?
|
| Calcium Oxalate | 2 | 2015 | 185 | 0.630 |
Why?
|
| Feeding Behavior | 1 | 2020 | 324 | 0.620 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2015 | 124 | 0.610 |
Why?
|
| Microscopy, Fluorescence | 3 | 2015 | 425 | 0.600 |
Why?
|
| Dietary Fats | 1 | 2017 | 135 | 0.580 |
Why?
|
| Durapatite | 1 | 2015 | 28 | 0.540 |
Why?
|
| Prostate | 2 | 2017 | 377 | 0.540 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 2232 | 0.530 |
Why?
|
| Poloxamer | 3 | 2017 | 29 | 0.530 |
Why?
|
| Electron Probe Microanalysis | 1 | 2015 | 8 | 0.520 |
Why?
|
| Animals | 33 | 2020 | 26581 | 0.470 |
Why?
|
| Mice | 17 | 2020 | 11352 | 0.460 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 429 | 0.460 |
Why?
|
| Surface-Active Agents | 2 | 2017 | 59 | 0.450 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 78 | 0.440 |
Why?
|
| Glycoproteins | 3 | 2000 | 234 | 0.420 |
Why?
|
| Models, Molecular | 9 | 2005 | 1286 | 0.410 |
Why?
|
| Colitis | 2 | 2014 | 239 | 0.400 |
Why?
|
| Organometallic Compounds | 3 | 2013 | 132 | 0.370 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 579 | 0.350 |
Why?
|
| Tumor Burden | 2 | 2020 | 288 | 0.310 |
Why?
|
| Neoplasm Invasiveness | 3 | 2020 | 552 | 0.310 |
Why?
|
| Prostatic Hyperplasia | 2 | 2019 | 88 | 0.300 |
Why?
|
| Muramidase | 3 | 2017 | 34 | 0.300 |
Why?
|
| Escherichia coli | 5 | 2004 | 597 | 0.290 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 556 | 0.290 |
Why?
|
| Binding Sites | 9 | 2004 | 1098 | 0.270 |
Why?
|
| Calcium | 4 | 2002 | 1156 | 0.270 |
Why?
|
| Molecular Structure | 6 | 2007 | 287 | 0.250 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2015 | 111 | 0.240 |
Why?
|
| Protein Conformation | 7 | 2004 | 881 | 0.240 |
Why?
|
| Cations, Divalent | 1 | 2003 | 39 | 0.230 |
Why?
|
| Pyrophosphatases | 1 | 2003 | 16 | 0.230 |
Why?
|
| Ions | 2 | 2000 | 74 | 0.230 |
Why?
|
| Gadolinium | 3 | 2015 | 103 | 0.230 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 391 | 0.230 |
Why?
|
| Kinetics | 7 | 2004 | 1513 | 0.210 |
Why?
|
| Methyl Methanesulfonate | 1 | 2002 | 4 | 0.210 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 1720 | 0.210 |
Why?
|
| Carboxypeptidases | 2 | 1994 | 35 | 0.210 |
Why?
|
| Rats | 8 | 2013 | 3990 | 0.210 |
Why?
|
| Neoplasms | 4 | 2020 | 2897 | 0.200 |
Why?
|
| Female | 14 | 2020 | 44507 | 0.200 |
Why?
|
| Cyclic N-Oxides | 3 | 1993 | 33 | 0.190 |
Why?
|
| Polyethylene Glycols | 2 | 2017 | 363 | 0.190 |
Why?
|
| Glutamic Acid | 1 | 2001 | 152 | 0.190 |
Why?
|
| Cattle | 4 | 2007 | 376 | 0.190 |
Why?
|
| Water | 4 | 2008 | 275 | 0.190 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 197 | 0.180 |
Why?
|
| Organ Size | 1 | 2020 | 364 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 3092 | 0.160 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 2426 | 0.160 |
Why?
|
| Dietary Sugars | 1 | 2018 | 8 | 0.160 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 12 | 0.160 |
Why?
|
| Diet, Fat-Restricted | 1 | 2018 | 30 | 0.160 |
Why?
|
| Injections, Intravenous | 2 | 2015 | 244 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 1540 | 0.160 |
Why?
|
| Ligands | 3 | 2016 | 433 | 0.160 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2017 | 21 | 0.150 |
Why?
|
| Weaning | 1 | 2017 | 25 | 0.150 |
Why?
|
| Catalysis | 5 | 2003 | 203 | 0.150 |
Why?
|
| Ethylenediamines | 1 | 2017 | 14 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2018 | 130 | 0.150 |
Why?
|
| Protein Unfolding | 1 | 2017 | 12 | 0.150 |
Why?
|
| Protein Aggregates | 1 | 2017 | 20 | 0.150 |
Why?
|
| Adiposity | 1 | 2017 | 70 | 0.150 |
Why?
|
| ADAM17 Protein | 1 | 2016 | 9 | 0.150 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 16 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2011 | 663 | 0.150 |
Why?
|
| Protein Denaturation | 2 | 2007 | 106 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 44 | 0.140 |
Why?
|
| Simian virus 40 | 1 | 2015 | 35 | 0.130 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2015 | 47 | 0.130 |
Why?
|
| Carboxypeptidases A | 3 | 2007 | 11 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2014 | 1204 | 0.130 |
Why?
|
| Muscle, Skeletal | 2 | 2010 | 449 | 0.130 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 53 | 0.130 |
Why?
|
| ErbB Receptors | 2 | 2016 | 485 | 0.130 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 33 | 0.130 |
Why?
|
| Epithelium | 1 | 2015 | 319 | 0.120 |
Why?
|
| Models, Animal | 1 | 2015 | 263 | 0.120 |
Why?
|
| Glycolysis | 1 | 2015 | 129 | 0.120 |
Why?
|
| Image Enhancement | 3 | 2020 | 563 | 0.120 |
Why?
|
| Diffusion | 1 | 2013 | 93 | 0.120 |
Why?
|
| Acylation | 3 | 2004 | 38 | 0.120 |
Why?
|
| Artifacts | 1 | 2015 | 244 | 0.120 |
Why?
|
| Circular Dichroism | 3 | 2000 | 117 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 133 | 0.120 |
Why?
|
| Receptors, Calcitriol | 1 | 2014 | 129 | 0.120 |
Why?
|
| Radiography | 1 | 2015 | 813 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 156 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 3 | 2012 | 353 | 0.110 |
Why?
|
| Penicillanic Acid | 2 | 2004 | 11 | 0.110 |
Why?
|
| Freezing | 2 | 2004 | 33 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 53 | 0.110 |
Why?
|
| Solutions | 3 | 2005 | 85 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 1219 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 329 | 0.110 |
Why?
|
| Hydrolysis | 2 | 2004 | 141 | 0.110 |
Why?
|
| Niacinamide | 1 | 2012 | 116 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 113 | 0.110 |
Why?
|
| Microvessels | 2 | 2009 | 70 | 0.100 |
Why?
|
| Male | 8 | 2019 | 40956 | 0.100 |
Why?
|
| Solvents | 2 | 2002 | 96 | 0.100 |
Why?
|
| Mice, Nude | 2 | 2011 | 790 | 0.100 |
Why?
|
| Deuterium | 2 | 2001 | 33 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2011 | 94 | 0.100 |
Why?
|
| Molecular Conformation | 3 | 2005 | 96 | 0.100 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 80 | 0.100 |
Why?
|
| Intestines | 1 | 2013 | 411 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 311 | 0.090 |
Why?
|
| Camellia sinensis | 1 | 2009 | 6 | 0.090 |
Why?
|
| Angiogenesis Modulating Agents | 1 | 2009 | 4 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2010 | 334 | 0.090 |
Why?
|
| Serum Albumin | 1 | 2009 | 130 | 0.080 |
Why?
|
| Protein Structure, Secondary | 2 | 2017 | 330 | 0.080 |
Why?
|
| Humans | 12 | 2019 | 86601 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 589 | 0.080 |
Why?
|
| Protons | 3 | 2008 | 98 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 45 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 763 | 0.080 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 91 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2009 | 244 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 104 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 1990 | 0.070 |
Why?
|
| Progesterone | 1 | 2007 | 110 | 0.070 |
Why?
|
| Drug Design | 1 | 2007 | 124 | 0.070 |
Why?
|
| Algorithms | 3 | 2010 | 1830 | 0.070 |
Why?
|
| Pregnancy | 1 | 2013 | 2893 | 0.070 |
Why?
|
| Protein Binding | 3 | 2002 | 1456 | 0.070 |
Why?
|
| Substrate Specificity | 3 | 2004 | 347 | 0.070 |
Why?
|
| Protein Renaturation | 1 | 2005 | 4 | 0.070 |
Why?
|
| Injections | 2 | 2017 | 109 | 0.070 |
Why?
|
| Receptor, Insulin | 1 | 2005 | 54 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1753 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2005 | 102 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2005 | 69 | 0.070 |
Why?
|
| Models, Biological | 2 | 2009 | 1749 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 2887 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2004 | 408 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 2705 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 938 | 0.060 |
Why?
|
| Buffers | 1 | 2004 | 26 | 0.060 |
Why?
|
| Enterobacter cloacae | 1 | 2004 | 8 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2004 | 38 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2005 | 485 | 0.060 |
Why?
|
| Manganese | 1 | 2003 | 53 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 493 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 549 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2009 | 730 | 0.060 |
Why?
|
| Magnesium | 1 | 2003 | 177 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 378 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 666 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 115 | 0.050 |
Why?
|
| Chickens | 2 | 2017 | 212 | 0.050 |
Why?
|
| Surface Properties | 1 | 2002 | 130 | 0.050 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2001 | 3 | 0.050 |
Why?
|
| Penicillin G | 1 | 2001 | 4 | 0.050 |
Why?
|
| Asparagine | 1 | 2001 | 29 | 0.050 |
Why?
|
| Vanadium Compounds | 1 | 2000 | 2 | 0.050 |
Why?
|
| Cysteine | 1 | 2002 | 135 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2003 | 460 | 0.050 |
Why?
|
| Malonates | 1 | 2000 | 11 | 0.050 |
Why?
|
| Magnetics | 1 | 2000 | 41 | 0.050 |
Why?
|
| Anisotropy | 1 | 2000 | 62 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 279 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 370 | 0.050 |
Why?
|
| beta-Lactams | 1 | 2000 | 14 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2015 | 1924 | 0.050 |
Why?
|
| Nitrogen | 1 | 2000 | 70 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2000 | 270 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 193 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 503 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 2062 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3030 | 0.040 |
Why?
|
| Fructose | 1 | 2018 | 35 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 482 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 639 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 332 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 294 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2016 | 50 | 0.040 |
Why?
|
| Spiro Compounds | 1 | 2016 | 25 | 0.040 |
Why?
|
| Estradiol | 1 | 2017 | 252 | 0.040 |
Why?
|
| Diet, Western | 1 | 2016 | 37 | 0.040 |
Why?
|
| Metals | 1 | 1996 | 90 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1994 | 989 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2019 | 471 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 464 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 1994 | 736 | 0.030 |
Why?
|
| Cations | 1 | 1995 | 30 | 0.030 |
Why?
|
| Breast | 1 | 2017 | 286 | 0.030 |
Why?
|
| Porphyrins | 1 | 1995 | 39 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 181 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2014 | 26 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1565 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 3241 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 1241 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2014 | 94 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1994 | 28 | 0.030 |
Why?
|
| Succinates | 1 | 1994 | 21 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2014 | 96 | 0.030 |
Why?
|
| Oxyquinoline | 1 | 2013 | 4 | 0.030 |
Why?
|
| Amino Acids | 1 | 1995 | 252 | 0.030 |
Why?
|
| Perfusion | 1 | 2014 | 203 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2013 | 14 | 0.030 |
Why?
|
| Mammography | 1 | 2017 | 461 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 25 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 37 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2013 | 72 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 154 | 0.030 |
Why?
|
| Kidney Calculi | 1 | 1996 | 339 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 1993 | 14 | 0.030 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1993 | 42 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 427 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 8475 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 458 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2015 | 530 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 44 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 554 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 363 | 0.020 |
Why?
|
| Glioma | 1 | 2013 | 285 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 102 | 0.020 |
Why?
|
| Hindlimb | 1 | 2010 | 89 | 0.020 |
Why?
|
| Peptides | 1 | 1994 | 639 | 0.020 |
Why?
|
| Angiography | 1 | 2011 | 208 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1531 | 0.020 |
Why?
|
| Extremities | 1 | 2011 | 165 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 758 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2002 | 1014 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 674 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 90 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1284 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2008 | 106 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1578 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2008 | 52 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2008 | 125 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 18402 | 0.020 |
Why?
|
| Liver | 1 | 1993 | 1229 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 751 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1565 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 839 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 167 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 25017 | 0.020 |
Why?
|
| Pyrones | 1 | 2005 | 8 | 0.020 |
Why?
|
| Glycogen Synthase | 1 | 2005 | 22 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2005 | 32 | 0.020 |
Why?
|
| Electroporation | 1 | 2005 | 55 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 25640 | 0.020 |
Why?
|
| Tyrosine | 1 | 2005 | 133 | 0.020 |
Why?
|
| Glycogen | 1 | 2005 | 59 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 1078 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2008 | 574 | 0.020 |
Why?
|
| Adipocytes | 1 | 2005 | 155 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2005 | 692 | 0.020 |
Why?
|
| Amino Acids, Acidic | 1 | 2002 | 1 | 0.010 |
Why?
|
| Lithostathine | 1 | 2002 | 2 | 0.010 |
Why?
|
| Dialysis | 1 | 2002 | 24 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2005 | 377 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 1106 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 145 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 339 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 2000 | 10 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 5209 | 0.010 |
Why?
|
| Culture Media | 1 | 2000 | 147 | 0.010 |
Why?
|
| Static Electricity | 1 | 2000 | 89 | 0.010 |
Why?
|
| Tryptophan | 1 | 1994 | 90 | 0.010 |
Why?
|
| Alcohols | 1 | 1993 | 14 | 0.010 |
Why?
|
| Horses | 1 | 1993 | 35 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1994 | 179 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1993 | 58 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 3967 | 0.010 |
Why?
|